Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pain, Postoperative × Midazolam × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 11 Breast Neoplasms 8 Carcinoma, Non-Small-Cell Lung 7 Lung Neoplasms 5 Prostatic Neoplasms 4 Solid Tumor 3 Neoplasm Metastasis 3 Melanoma 3 Recurrence 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Gastrointestinal Stromal Tumors 2 Colonic Neoplasms 2 Carcinoma 2 Advanced Solid Tumor 2 cMET-dysregulated Advanced Solid Tumors 1 Terminal Cancer 1 Synovitis, Pigmented Villonodular 1 Solid Tumours 1 Solid Tumour 1 Solid Tumors 1 Skin Neoplasms 1 Respiratory Aspiration 1 Respiration Disorders 1 Rectal Neoplasms 1 Rare Diseases 1 Polyps 1 Pharmacokinetics of MDV3100 1 Patient Satisfaction 1 Pancreatic Neoplasms 1

Interventions

Bupivacaine 16 Saline Solution 8 Ropivacaine 8 Dexmedetomidine 7 Sodium Chloride 5 Pregabalin 5 Morphine 5 Lidocaine 4 Ketamine 4 Dexamethasone 4 Control Groups 4 Tea 3 Analgesia, Patient-Controlled 3 Acetaminophen 3 Population Groups 2 Parapsychology 2 Magnesium Sulfate 2 Injections, Epidural 2 Gabapentin 2 Fentanyl 2 Dental Occlusion 2 Anesthetics, Local 2 Analgesics, Opioid 2 thiamine triphosphorate 1 ramosetron 1 parecoxib 1 gamma-Aminobutyric Acid 1 esmolol 1 Water 1 Vitamins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06315634 2024-03-18

Intrathecal Dexmedetomidine vs Midazolame

National Cancer Institute, Egypt

Phase 4 Completed

Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡